Lisa Schlicher - Concepedia

Author

Lisa Schlicher

University of Freiburg ORCID

Also Known As

Christian Imwalle, L SCHLICHER, L. Schlicher, Lisa Schlicher, Schlicher, Lisa

Publications

579

Citations

H-Index

Concepts

All Affiliations

University of Freiburg University of Oxford Ludwig Cancer Research Tufts University University of Houston

About

Lisa Schlicher is an author at University of Freiburg specializing in signal transduction, cell signaling, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	148
2	Cell Biology	2	2	130
3	Natural Sciences	1	1	20
4	Cellular Physiology	1	1	110
5	Immunology	1	1	110

Lisa Schlicher

Publications

466

Citations

H-Index

Page 1

	Year	Citations
GSK-3 – at the crossroads of cell death and survival Ulrich Maurer, Florian Preiss, Prisca Brauns‐Schubert, Journal of Cell Science	2014	178
<scp>SPATA</scp> 2 promotes <scp>CYLD</scp> activity and regulates <scp>TNF</scp> ‐induced <scp>NF</scp> ‐κB signaling and cell death Lisa Schlicher, Manuela Wissler, Florian Preiss, EMBO Reports InflammationCytokineTranscriptional RegulationSignal TransductionSignaling Pathway	2016	110
Small molecule inhibitors reveal an indispensable scaffolding role of <scp>RIPK</scp> 2 in <scp>NOD</scp> 2 signaling Matouš Hrdinka, Lisa Schlicher, Bing Dai, The EMBO Journal	2018	74
Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains P.R. Elliott, Derek Leske, Jane L. Wagstaff, Cell Reports	2021	37
CDK9‐mediated phosphorylation controls the interaction of TIP60 with the transcriptional machinery Prisca Brauns‐Schubert, Manuela Wissler, Lisa Schlicher, EMBO Reports Transcriptional RegulationSignal TransductionSignaling PathwayCell RegulationMolecular Regulation	2018	20
Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold Chalada Suebsuwong, Bing Dai, Daniel M. Pinkas, European Journal of Medicinal Chemistry	2020	19
Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling Sameer Nikhar, Ioannis Siokas, Lisa Schlicher, European Journal of Medicinal Chemistry Drug TargetSignal TransductionSignaling PathwayMedicineReceptor Tyrosine Kinase	2021	18
Requirement of GSK-3 for PUMA induction upon loss of pro-survival PI3K signaling J. Rapp, Prisca Brauns‐Schubert, Lisa Schlicher, Cell Death and Disease	2018	10

Page 1